EnteroMedics Gets CE Mark For Anti-Obesity Device
EnteroMedics received the European CE Mark Certification for the Maestro RC System, the St. Paul, Minnesota company announced.
EnteroMedics received the European CE Mark Certification for the Maestro RC System, the St. Paul, Minnesota company announced.
CryoLife, an implantable biological medical device and cardiovascular tissue processing company, agreed to acquire surgical product maker, Cardiogenesis Corp. for about $22 million.
NeoStem , an international biopharmaceutical company, will present at OneMedForum NY 2011.
Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, announced that its test was recently featured in Diagnostic and Interventional Cardiology as the Case of the Week.
Anavex Life Sciences recently announced that its clinical trial application for ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease, has been approved by the German regulatory health authority.
SynCardia Systems Inc, the Tucson-based manufacturer of the world’s only Total Artificial Heart, announced recently that St. Vincent’s Hospital in Sydney, Australia, has successfully bridged its first patient to transplant.
OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare, has received FDA 510k clearance for Enhanced Flow Meter Visualization.
UCSF doctors have developed a test that, using just a drop of blood taken within hours of a baby’s birth, can determine whether that child has a rare but potentially fatal immune deficiency disorder.
A new non-surgical, tissue-preserving therapeutic procedure is being developed to more effectively remove HPV infection and treat precursors of cervical cancer.
OneMedForum is pleased to announce the assembly of the OneMedForum NY 2011 Steering Committee.
Copyright © 2024 | WordPress Theme by MH Themes